Chemical Compound

13-Ehgeo

CAS Registry Number 793-55-5
Back to search Request a Quote
13-Ehgeo chemical structure
Primary Record

13-Ehgeo

In stock
6,565 g
Purity
99.3 %
CAS
793-55-5

Compound Identifiers & Properties

CAS
793-55-5
PubChem CID
10039774
SMILES
CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34
Canonical SMILES
CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2O

Names & Synonyms

  • 13-Ehgeo
  • Ethylnandorolone
  • 18-Methyl Nandrolone
  • 18-Methyl-19-nortestosterone
  • Levonorgestrel EP Impurity K
  • RefChem:437589
  • 2B802ECT5B
  • 6AL6ML53DZ
  • UNII-6AL6ML53DZ
  • UNII-2B802ECT5B
  • 13-Ethyl-17-hydroxy-gon-4-en-3-one
  • DTXSID101237364
  • SCHEMBL4437111
  • DEA No. 4000
  • Wy 3016
  • FBYZQDCRLYHHHP-ZOFHRBRSSA-N
  • 13-ethyl-17beta-hydroxygon-4-en-3-one
  • DTXCID701668290
  • 13Beta-ethyl-17beta-hydroxygon-4-en-3-one
  • 793-55-5
  • RU-3366
  • ZINC5955127
  • Norgestrel impurity D [EP impurity]
  • C19-H28-O2
  • CS-O-14090
  • DB01543
  • RU 3366
  • WY-3016
  • 793-54-4
  • CID10039774
  • 13-Ethyl-17|A-hydroxygon-4-en-3-one
  • 17|A-Hydroxy-13-ethylgon-4-en-3-one
  • 17beta-hydroxy-13-ethylgon-4-en-3-one
  • PD060340
  • rac-13-Ethyl-17beta-hydroxygon-4-en-3-one
  • 18-METHYLNANDROLONE [EP IMPURITY]
  • 17beta-Hydroxy-13-ethylgona-4-ene-3-one
  • 17beta-Hydroxy-18-methylestr-4-en-3-one
  • J621.100C
  • NS00070121
  • 13beta-Ethyl-17beta-hydroxy-gon-4-en-3-one
  • LEVONORGESTREL IMPURITY K [EP IMPURITY]
  • (17|A)-13-Ethyl-17-hydroxygon-4-en-3-one
  • (17beta)-13-Ethyl-17-hydroxygon-4-en-3-one
  • 18-Methyl Nandrolone (1.0mg/ml in Acetonitrile)
  • 13-ETHYL-17.BETA.-HYDROXYGON-4-EN-3-ONE
  • Gon-4-en-3-one,13-ethyl-17-hydroxy-,(17beta)-
  • (+/-)-13beta-Ethyl-17beta-hydroxygon-4-ene-3-one
  • Gon-4-en-3-one, 13-ethyl-17-hydroxy-, (17beta)-(+-)-
  • Q27264417
  • 17beta-Hydroxy-13beta-ethyl-4-gonen-3-one, (+/-)-
  • Gon-4-en-3-one, 13-ethyl-17-hydroxy-, (17beta)-
  • 13.BETA.-ETHYL-17.BETA.-HYDROXYGON-4-EN-3-ONE
  • DL-13.BETA.-ETHYL-17.BETA.-HYDROXYGON-4-EN-3-ONE
  • GON-4-EN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.BETA.)-
  • (1S,3aS,3bR,9aR,9bS,11aS)-11a-ethyl-1-hydroxy-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one
  • (8R,9S,10R,13S,14S,17S)-13-ethyl-17-hydroxy-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
  • GON-4-EN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.BETA.)-(+/-)-
  • (1S,3aS,3bR,9aR,9bS,11aS)-11a-Ethyl-1-hydroxy-1,2,3,3a,3b,4,5,8,9,9a,9b,10,11,11a-tetradecahydro-7H-cyclopenta[a]phenanthren-7-one
  • (8R,9S,10R,13S,14S,17S)-13-ethyl-17-hydroxy-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
  • Gon-4-en-3-one, 13-ethyl-17-hydroxy-, (17ss)-; Gon-4-en-3-one, 13-ethyl-17ss-hydroxy- (7CI,8CI); 13-Ethyl-17ss-hydroxygon-4-en-3-one; 17ss-Hydroxy-13-ethylgon-4-en-3-one; 18-Methyl-19-nortestosterone; RU 3366; 13-Ethyl-17ss-hydroxygon-4-en-3-one (18-Methylnandrolone); Levonorgestrel Imp. K (EP); Gon-4-en-3-one, 13-ethyl-17-hydroxy-, (17beta)-; Gon-4-en-3-one, 13-ethyl-17beta-hydroxy- (7CI,8CI); 13-Ethyl-17beta-hydroxygon-4-en-3-one; 17beta-Hydroxy-13-ethylgon-4-en-3-one; 18-Methyl-19-nortestosterone; RU 3366; 13-Ethyl-17beta-hydroxygon-4-en-3-one (18-Methylnandrolone);